RSS

strategic agreement

A strategic agreement has been signed by GlaxoSmithKline (GSK) and Orchard Therapeutics, involving the transfer of GSK’s portfolio of approved and investigational rare disease gene therapies to Orchard. more

News

A strategic partnership has been announced between biopharmaceutical contract services company, KBI, and provider of formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics, ReForm more

News

Rentschler Biopharma and Leukocare have reported the success of the first year of their strategic alliance, incorporating formulation development in each step of the biopharmaceutical development and manufacturing process. more

News

Canadian company, Aphria, has announced a $11.5 million strategic investment into biopharmaceutical company, Scientus Pharma, which focuses on the development of drugs that target the endocannabinoid receptors to treat diseases. more

News

Cresset, a provider of software and contract research services for small molecule discovery and design, has signed a three-way strategic agreement to speed up drug design. more

News